India Brokerage Recommendations : Stock advices for first week of march

This post covers some of the recommendations and advices of the Indian brokerage and research firms that came out in the first week of March. This is a follow up to my first post where I started tracking the recommendations from Indian brokerage and research firms.

In the last week - Aurobindo Pharma had two BUY calls, a number of IT companies also had a BUY and there was one REDUCE for Ranbaxy. The following is the list

Date	Brokerage/Research Firm Name	Stock	Recommendation	Target	Price on the date of recommendation
5-Mar-10	Prabhudas Lilladher	Infosys	BUY	3,250
5-Mar-10	Firstcall Research	NIIT	HOLD	76	66.5
5-Mar-10	Firstcall Research	Bilpower	HOLD	205	177.65
5-Mar-10	Reliance Securities	Dishman Pharma	HOLD	238	208
4-Mar-10	Firstcall Research	SREI Infra	BUY	90	73.45
4-Mar-10	Firstcall Research	Mundra Port	BUY	790	709
5-Mar-10	Karvy	Inox Leisure	MARKET PERFORMER	79
3-Mar-10	Sunidhi Securities	KPIT Cummins	BUY	140	112
4-Mar-10	Angel Securities	Balrampur Chini	NEUTRAL
3-Mar-10	Firstcall Research	Jyoti Structures	BUY	200	161
3-Mar-10	Firstcall Research	Tata Power	HOLD	1499
3-Mar-10	Emkay	South Indian Bank	BUY	180
3-Mar-10	SKP Research	Aurobindo Pharma	BUY	1800
3-Mar-10	Angel Securities	Ranbaxy Labs	REDUCE	445
3-Mar-10	Anand Rathi	Pratibha Industries	BUY	501	350
3-Mar-10	Hem Securities	Videocon Ind	BUY	280
2-Mar-10	Motilal Oswal	Financial Tech	BUY	1822
3-Mar-10	Karvy	Aurobindo Pharma	BUY	1283	970
26-Feb-10	Angel Securities	Tata Motor	BUY	942

RK

Tracking India Brokerage And Research Firms Stock Advices

Brokerage and independent research firms regularly come out with stock recommendations to help out the retail investors. But what we don't hear is how their recommendations and advices actually performed. So I am going to try to make an effort to gather the recommendations from various brokerages and track their performance. If I find the stocks picked by these firms perform then making money would be as easy as following their advice.

The following is the initial list gathered based on the recommendations from the last 2 weeks of this month. I will update this list once in a week or two and add on performance after a period of 3 months.

Date	Brokerage/Research Firm Name	Stock	Recommendation	Target	Price on the date of recommendation
26-Feb-10	ULJK Research	Polaris	BUY	197	146
26-Feb-10	FinQuest Securities	Yes Bank	BUY	315	236
26-Feb-10	Karvy	Kalpataru Power	BUY	1292	1026.2
26-Feb-10	Karvy	Bharti Airtel	MARKET PERFORMER	315	276
26-Feb-10	Karvy	Aventis Pharma	MARKET PERFORMER	1823	1630
25-Feb-10	Motilal Oswal	Mphasis	NEUTRAL	710	673
25-Feb-10	Anand Rathi	Bharti Airtel	SELL	325	276
25-Feb-10	Anand Rathi	Mphasis	BUY	890	673
25-Feb-10	ULJK Securities	Sunil Hitech	BUY	282	198
25-Feb-10	Emkay Global	Mphasis	HOLD		673
24-Feb-10	Firstcall Research	Mawana Sugars	BUY	42	33.7
24-Feb-10	Firstcall Research	Binani Cement	BUY	84	69.85
24-Feb-10	Firstcall Research	Indian Hotels	NEUTRAL		86
24-Feb-10	Firstcall Research	Torrent Cables	BUY	132	115
22-Feb-10	KRChoksey	Nestle India	HOLD	2786	2580
22-Feb-10	Motilal Oswal	GSK Pharma	BUY	1800	1681.75
22-Feb-10	Prabhudas Lilladher	KPIT Cummins	ACCUMULATE	150	108.85
22-Feb-10	IndiaInfoline	HDIL	BUY	333	294
22-Feb-10	Karvy	Shree Renuka	BUY	270	180
20-Feb-10	Firstcall Research	Kalindee Rail	HOLD	255	213.95
20-Feb-10	Firstcall Research	Allied Digital	BUY	260	220.3
19-Feb-10	Bonanza	Action Construction Equipment	HOLD		37
19-Feb-10	Parag Parikh Research	GlaxoSmithKline Pharma	ACCUMULATE		1650
19-Feb-10	Sunidhi Securities & Finance	Renaissance Jewellery	BUY	100	70
19-Feb-10	Karvy	ITC	MARKET PERFORMER	286	249
18-Feb-10	Angel Securities	Hindalco	ACCUMULATE	179	152
18-Feb-10	Karvy	PVR	UNDER PERFORMER	154	172
18-Feb-10	HDFC Sec	IVRCL Infra	BUY	372	315
17-Feb-10	Motilal Oswal	Tata Steel	NEUTRAL
17-Feb-10	Angel Securities	Tata Steel	BUY	697	585
17-Feb-10	KRChoksey	Tata Steel	BUY	718	584
16-Feb-10	Hedge Equities	Pratibha Inds	ACCUMULATE	447-521	328